Chronic alcoholism is associated with a high prevalence of riboflavin deficiency. Experiments were designed in an animal model to determine whether ethanol alters selectively the absorption of riboflavin and flavin adenine dinucleotide (FAD), the predominant dietary form of the vitamin. Rats received by gavage a liver homogenate to which either I14Clriboflavin or I14C]FAD was added with either ethanol or isocaloric sucrose solutions.
Introduction
Numerous reports have documented a high prevalence of riboflavin (vitamin B2) deficiency in alcoholic patients (1) (2) (3) (4) (5) (6) (7) (8) . In some instances, flagrant manifestations of clinically advanced deficiency are apparent in the form of glossitis and cheilosis (4, 5) . More commonly, evidence of deficiency is based upon biochemical laboratory tests, including decreased urinary excretion of riboflavin, low serum levels of riboflavin, and elevated activity coefficient of erythrocyte glutathione reductase, an enzyme marker for riboflavin deficiency (9-1 1). Estimates of the prevalence of riboflavin deficiency among alcoholics have generally varied between 15 and 50% based on the laboratory and clinical evidence examined (2, 5) . Deficits of riboflavin in alcoholism could lead to skin disorders (12), changes in metabolism of xenobiotic substances (13, 14) , abnormalities ofendocrine function (15) (16) (17) (18) , disturbances in lipid metabolism (19, 20) , interference with energy utilization (21) , and personality deterioration (22, 23) .
Lack of riboflavin in alcoholics has usually been observed in association with deficiencies of other nutrients (1, 3, (24) (25) (26) , perhaps because a diet poor in one nutrient is generally poor in others. Furthermore, since riboflavin is involved in the metabolic transformations of folic acid (27, 28) , pyridoxine (29, 30) , vitamin K (31), and niacin (32), decreased dietary intake of riboflavin would also increase the likelihood of developing either secondary deficiencies or alterations in metabolism of these vitamins.
Despite widespread recognition that riboflavin deficiency is a common feature of alcoholism, little is understood of its pathogenesis. It is not known whether riboflavin deficiency under these circumstances is due entirely to inadequate dietary intake ofthis key vitamin, or whether alcohol exerts specific and direct effects on metabolism of riboflavin or of any of its derivatives. In general, vitamin deficiencies in alcoholism, are attributed to diminished intake, decreased absorption, and disturbances in metabolism (33) . To elucidate possible mechanisms underlying the pathogenesis of riboflavin deficiency in alcoholism, we have considered an animal model in which riboflavin and its coenzymic forms can be fed both in the presence and absence of alcohol, and flavin utilization can be determined subsequently.
These studies indicate that ethanol greatly diminishes the bioavailability ofriboflavin from the gastrointestinal tract, and particularly that of flavin adenine dinucleotide (FAD),' the form ofriboflavin predominantly present in food sources. By inhibiting the FAD degradative enzymes in intestinal mucosa, alcohol and its metabolite, acetaldehyde, either singly or in combination diminish the conversion of FAD to riboflavin, the form required for absorption.
Methods
Animals and diet. All experiments were performed on adult male rats (Holtzman Co, Madison, WI) weighing 150-250 g. Animals used in these experiments were maintained on tap water and standard pelleted Purina Rat Chow ad lib. (Ralston Purina Co., St. Louis, MO), which has been determined in this laboratory to contain riboflavin in - 8.5 Ag/g diet. Animals consuming this diet in normal amounts receive three times the recommended daily allowance for riboflavin in the rat.
Isotopes and chemicals. 28 mCi/mmol ['4Clriboflavin was purchased from Amersham Corp., Arlington Heights, IL, and its specific activity assayed in this laboratory before use. Nonradioactive riboflavin, riboflavin-5'-phosphate (flavin mononucleotide (FMN]), and FAD were purchased from Sigma Chemical Co., St. Louis, MO. All other chemicals were of the highest grade available commercially.
Alcohol administration and ["C]FAD formation in liver. Before all experiments, a normal rat was decapitated, and a liver homogenate prepared (1 g liver per 2 ml water). Liver was selected as the model food source because, ofall the common foods, it has the highest concentration of phosphorylated derivatives of riboflavin (as FMN and FAD) (17) . To this homogenate was added 1.4 X 105 dpm/ml ['4C]riboflavin and either ethanol to a final concentration of 20% or sucrose in an amount isocaloric with 20% ethanol. These preparations were used in subsequent alcohol studies by intubation. Animals used in the feeding experiments were fasted for 18 h before intubation. Each animal received an aliquot ofthe liver homogenate that contained ["C]riboflavin and 15 ml/kg body weight ofeither ethanol or sucrose by gavage. In further experiments, 1.4 X 101 dpm/ml ['4C]FAD was substituted for ['4C]riboflavin and a similar procedure followed. When maintained at 4VC before intubation, the ethanolic ['4C]FAD-containing liver homogenate contained negligible activities of FAD pyrophosphatase and FMN phosphatase, which were monitored by thin layer chromatographic separation of radiolabeled flavin derivatives.
Rats were decapitated at 2, 4, and 6 h after gastric intubation. Livers were removed promptly and assayed for ["CJFAD by using reverseisotope dilution and anion-exchange column chromatography with DEAE-Sephadex A-25 (Pharmacia Fine Chemicals, Division of Pharmacia Inc., Piscataway, NJ), as published previously from this laboratory (34) .
Preparation and mounting ofeverted intestinal segments and in vitro transport of["CC]riboflavin. To demonstrate selective effects of ethanol and acetaldehyde directly upon the luminal phase of flavin absorption, we examined the uptake of [14C]riboflavin both in the presence and absence of 100-fold excess ofnonradiolabeled FMN and FAD in isolated everted jejunal segments. Intestinal segments were prepared and jejunal sleeves were mounted using the procedure of Karasov and Diamond (35) . Jejunal segments were incubated at 37°C in mammalian Ringer's solution that contained 2.5 mM phenylalanine, which inhibits intestinal alkaline phosphatase but has no effect on FAD pyrophosphatase and minimal effect on FMN phosphatase activities [36] . Before incubation of the rod-mounted sleeves, Ringer's media that contained 31.3 nCi/ml ['4C~riboflavin alone or with either ofthe phosphorylated flavin derivatives (0.1 15 mM FMN or 0.124 mM FAD) were prepared to final dilutions with Ringer's solution, 10% ethanol, or 0.2% acetaldehyde and gassed with 5% C02-95% 02. After 20 min, incubations were terminated at timed intervals by removing the rod-mounted sleeves from incubation vessels and successively rinsing them for 15 s each in three beakers of 50 ml cold Ringer's solution without tracer. This postincubation rinse time was sufficient to remove adherent extracellular [4C]riboflavin. Tissue samples were drained of excess media by touching the tips of the rodmounts to filter paper. Mounted tissues were cut from between the sutures with a scalpel, placed in tared glass scintillation vials, and weighed (80-120 mg). All samples were prepared for counting by first incubating tissue at 100°C for 2 h in 1 N NaOH and then allowing vials to sit at room temperature overnight. After complete tissue solubilization (10-18 h), each sample was neutralized with HCI, mixed with 10 ml Hydrofluor (National Diagnostics, Inc., Advanced Applications Institute Inc., Somerville, NJ), and radioactivity determined in a Tricarb liquid scintillation spectrometer (Packard Instrument Co. Inc., Downers Grove, IL). ['4C]Riboflavin uptake per intestinal segment was determined as disintegrations per minute per milligram wet weight of tissue, and all incubations and procedures that involved riboflavin and its phosphorylated derivatives were performed under reduced lighting. FAD pyrophosphatase andFMNphosphatase assay in intestinal mucosal cells. Rats were fasted for 18 h before decapitation. The small intestine was removed promptly and rinsed with cold saline. The mucosal tissue was scraped offgently with a glass slide at4C. The cellular scrapings were homogenized for 30 s with iced 0.1 M Tris buffer, pH 8. The mucosal extracts were then centrifuged at 60,000 gfor 30 min, and the supernatant solution decanted and used for enzymatic assay.
To assay FAD pyrophosphatase, aliquots ofthe supernatant solutions were incubated at 37°C for 20 min with 0-20% ethanol or 0-2% acetaldehyde, and 6,000-8,000 dpm ['4C]FAD to a total volume of 0.5 ml. Boiled supernatant solutions were used as blanks, and all reaction mixtures were preincubated at room temperature for 5 min before initiating the reaction with radiolabeled FAD. The enzymic reaction was stopped with 7 ml absolute methanol. To 
Results
["C]Riboflavin as vitamin source. At intervals after rats' stomachs were intubated with a liver homogenate that contained
[14C]riboflavin and an equal volume of added sucrose, radiolabeled riboflavin was incorporated briskly into ["4C]FAD in their liver. Isotope incorporation increased progressively at 2, 4, and 6 h postintubation, as shown in Fig. 1 . In subsequent studies in which the homogenates were mixed with water rather than sucrose, an identical pattern of incorporation into [14C]FAD was noted. A summary of the effects of ethanol upon inhibiting the dietary utilization of riboflavin and FAD is shown in Table I . At 2 and 4 h post-gastric intubation with ethanol, dietary FAD incorporated into liver FAD is significantly less than with riboflavin as a vitamin source. At 6 h, no significant difference appeared in hepatic FAD that formed in a small number of animals when fed FAD or riboflavin as a vitamin source, by gastric intubation. It is essential to note that at all times, and with all samples, the levels of alcohol feeding were 50% or less than those of sucrose-fed animals.
In vitro transport of ["4C]riboflavin into evertedjejunal segments. The finding that ethanol diminished the bioavailability of FAD to a greater extent than that of riboflavin, raised the possibility that ethanol might diminish the hydrolysis of dietary FAD to riboflavin, the form in which vitamin B2 is absorbed from the intestine.
To test this hypothesis, we measured in everted intestinal segments the effects of ethanol and acetaldehyde directly on ['4C]riboflavin uptake in the presence and absence of nonradiolabeled FAD and FMN (Fig. 3 ). Exogenous addition of excess FAD or FMN to the incubation media would be expected to dilute the radiolabeled riboflavin pool after dephosphorylation of FAD and FMN by FAD pyrophosphatase and FMN phos- phatase, respectively. A schematic representation ofthe sequential dephosphorylation of FAD to riboflavin is outlined in Fig.  4 . As illustrated in Fig. 3 , intestinal segments incubated in Ringer's media alone demonstrated a marked uptake capacity for [14C]riboflavin. In the presence of 100-fold excess of either nonradiolabeled FAD or FMN and subsequent dephosphorylation to riboflavin, intestinal segments demonstrated a significant reduction in uptake of radiolabeled riboflavin, attributable to subsequent dilution of the intracellular ['4C]riboflavin fraction. If ethanol acts by inhibiting the activities of FAD pyrophosphatase and FMN phosphatase, then adding excess FAD or FMN to an ethanol-containing medium would be expected to generate less riboflavin than in a saline-containing medium in which the activities ofthese enzymes remain intact. The results of this experiment shown in Fig. 3 illustrated significantly less (P < 0.001) depression of radioactive riboflavin transport in alcohol-containing medium than in saline-containing medium.
Furthermore, in the absence of added FAD or FMN, transport of radioactive riboflavin across the mucosal membrane was similar in the saline-containing medium and the ethanol-containing medium, which indicated that the riboflavin transport process through the mucosal membrane was not appreciably damaged by ethanol.
Since small amounts of acetaldehyde are generated in the gastrointestinal tract after consumption of ethanol, we examined the effects of acetaldehyde on the mucosal transport of riboflavin and dephosphorylation of FAD and FMN. In an experimental design similar to that of the ethanol-containing and saline-containing media, intestinal segments were incubated with 0.2% acetaldehyde in the presence of FAD or FMN, which resulted in less depression of intracellular ['4C]riboflavin than with saline. The effect of acetaldehyde at this concentration was not as pronounced as that observed in the presence of ethanol, and riboflavin transport was in fact intermediate between that observed in saline-containing and ethanol-containing media. It is important to note that in the absence of added FAD or FMN, intracellular ['4C]riboflavin accumulated in 0.2% acetaldehydecontaining medium alone at a level comparable to that in the saline-containing medium, which indicated that the mucosal membrane transport of riboflavin was not altered significantly by acetaldehyde.
Effects ofethanol and acetaldehyde on the activities ofFMN phosphosphatase and FAD pyrophosphatase. To investigate further the direct effects of both ethanol and acetaldehyde on flavin nucleotide absorption, we measured the activities of the two FAD hydrolytic enzymes, FAD pyrophosphatase (FAD --FMN) and FMN phosphatase (FMN --riboflavin), in extracts of intestinal mucosal cells. Studies were performed with increasing concentrations of ethanol incubated in vitro in the enzyme reaction, and were compared with findings with sucrose as a control.
The data from these studies are in Table II . Both enzymes were inhibited by ethanol in vitro, beginning at a 5% concentration. At each concentration of ethanol, FMN phosphatase was inhibited to a greater extent than FAD pyrophosphatase.
Since a number of the metabolic effects of ethanol are believed due not to ethanol itself, but to its metabolite, acetaldehyde, activities of these hydrolytic enzymes were assayed after intubation with this agent in vitro. As shown in Table II , acetaldehyde at 10-fold lower concentrations than ethanol also markedly inhibited FAD pyrophosphatase activity in extracts from intestinal mucosal cells. An unexpected and repeatedly 10% ETHANOL 0.2% ACETALDEHYDE Figure 3 . Effects of nonradiolabeled FMN and FAD upon transport of ["C]riboflavin across jejunal segments both in the presence and absence of 10% ethanol and 0.2% acetaldehyde.
confirmed finding is that FMN phosphatase activity was actually increased markedly by acetaldehyde. However, the net effect of acetaldehyde was to diminish the overall hydrolysis of FAD to riboflavin.
Discussion
The results ofthe present study suggest that riboflavin deficiency in alcoholism likely arises not only from inadequate intake of this vitamin, but also from specific actions of ethanol, and possibly its major metabolite, acetaldehyde, on several aspects of riboflavin metabolism. Alcohol diminishes the bioavailability of both riboflavin and FAD, which suggests a probable effect on intestinal absorption. However, these findings do not exclude the possibility that alcohol may interfere additionally with egress of riboflavin from the intestinal mucosa, transport in serum, hepatic uptake, metabolic transformations in tissue, urinary excretion, or other processes.
The fact that the bioavailability of FAD is inhibited by alcohol to an even greater degree than that of riboflavin under these conditions suggests that alcohol has an important action on inhibiting the hydrolysis of FAD to riboflavin, which is required before its absorption. Evidence in support of this hypothesis is provided by the observation that both FAD degradative enzymes, FAD pyrophosphatase and FMN phosphatase, from intestinal mucosa are inhibited in vitro by alcohol. Acetaldehyde also inhibits FAD pyrophosphatase activity, but, curiously, enhances FMN phosphatase activity. Nevertheless, the net effect of these divergent actions of acetaldehyde and the combined effects of ethanol and acetaldehyde are to restrict sharply the amount of riboflavin derived from the hydrolysis of FAD subsequently available for absorption.
The differential effects of alcohol on FAD and riboflavin bioavailability may possibly have clinical implications for nutritional rehabilitation of alcoholic patients. Most food sources of riboflavin are in the form of FAD (17) ; it would be expected that food sources would be less efficiently utilized by the alcoholic patient than vitamin supplements, which are in the form of riboflavin itself. Since the bioavailability offood sources ofvitamin B2 appears to be affected more than vitamin preparations are by the deleterious effects of ethanol, the initial rehabilitation of riboflavin-deficient alcoholic patients theoretically might be accomplished more quickly and efficiently by vitamin therapy than with food sources. A similar conclusion has been reached with respect to folate, thiamine, and vitamin B6 (37). It will be important to determine the duration of the inhibitory effects of alcohol and the effects of chronic intake of alcohol since, in the present study, food sources and alcohol were administered simultaneously. The sequence ofevents in the conversion offood FAD to hepatic FAD is shown in Fig. 4 . Little attention has been given to the possible role of riboflavin nutriture in determining any ofthe physiological or clinical disorders associated with alcoholism. Riboflavin deficiency results in a decrease in the removal rate ofethanol (13) and therefore may be one ofthe factors governing the duration ofalcohol action. Although metabolism ofacutely administered alcohol is believed to be mediated by the inducible enzyme, alcohol dehydrogenase, chronically administered alcohol is also catabolized by a microsomal enzyme system that requires flavin coenzymes (38) (39) (40) . It has been observed that riboflavin administration normalizes elevated alcohol dehydrogenase activity with ethanol as a substrate (41), and when combined with pyruvate and dihydroxyacetone, prevents fatty liver caused by alcohol (42) . Psychotropic drugs, such as chlorpromazine, imipramine, and amitriptyline, which may be administered to or utilized by alcoholic patients, interfere sensitively with riboflavin utilization and may strain further the already depleted riboflavin reserves (43) (44) (45) . Flavin metabolism in cardiac tissue is particularly sensitive to the action of these agents; thus, riboflavin-deficient alcoholic patients may be at increased risk for developing cardiac arrhythmias with chronic usage of psychotropic drugs (46, 47) . While the Wernicke-Korsakoff syndrome in alcoholism is widely attributed to alterations associated with a deficiency of thiamine, it is not generally appreciated that even minor degrees ofriboflavin deficiency may have important effects on personality (22, 23, 48, 49) . In addition, riboflavin deficiency leads to a depression ofantibody-forming cells in the spleen, which results in decreased immune responsiveness in experimental animals and increased susceptibility to infection (50) . Riboflavin deficiency alters the tissue and plasma concentrations of phospholipids (20) and increases the rate of biosynthesis of renal prostaglandins (5 1). In view of the known role of riboflavin in lipid and amino acid metabolism, energy generation and utilization, and vitamin metabolism, riboflavin deficiency caused by alcoholism may have far-reaching implications for health in alcoholic patients.
Further research is needed to determine the precise sites of action ofethanol on intracellular riboflavin metabolism, to clarify food-alcohol-drug interrelations, and to design more sensitive methods for biochemical evaluation ofriboflavin status than are currently available.
